Skip to the page

Data / Form D filings / THAR PHARMACEUTICALS INC

THAR PHARMACEUTICALS INC: Form D filings

THAR PHARMACEUTICALS INC, a pharmaceuticals company in Pittsburgh, PA, filed 10 Form D notices with the SEC between 2009 and 2016. The latest, on April 5, 2016, reports $1.4 million sold of a $3 million offering to 18 investors.

Find out what THAR PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
150 GAMMA DRIVE, Pittsburgh, PA, 15238
Phone
(412) 968-0200
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1428369

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 5, 2016Amendment$3,000,000$1,371,500$1,628,50018Aug 19, 2014sec.gov
Sep 2, 2014New notice$3,000,000$115,000$2,885,0002Aug 19, 2014sec.gov
Nov 12, 2013Amendment$5,000,000$3,940,000$1,060,00032Nov 14, 2012sec.gov
Apr 19, 2013Amendment$5,000,000$1,950,000$3,050,00021Oct 26, 2011sec.gov
Nov 30, 2012New notice$2,000,000$405,000$1,595,0006Oct 26, 2011sec.gov
Jul 3, 2012Amendment$2,500,000$325,000$2,175,0003Oct 26, 2011sec.gov
Nov 18, 2011New notice$1,000,000$250,000$750,0001Oct 26, 2011sec.gov
Jan 3, 2011Amendment$9,636,000$4,311,656$5,324,3445Nov 29, 2010sec.gov
Dec 8, 2010New notice$8,092,792$2,025,000$6,067,7925Nov 29, 2010sec.gov
Dec 21, 2009Amendment$1,500,000$1,242,000$258,0006Jan 7, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Raymond K. HouckExecutive Officer, Director
Lalit K. ChordiaDirector
Mazen K. HannaExecutive Officer
Ira K. KalfusExecutive Officer
Philip K. SussmanDirector
Robert K. RoyDirector
Jason K. BablakExecutive Officer
Brian K. MoyerExecutive Officer

Other pharmaceuticals companies in Pennsylvania that filed recently

Every Form D from the week of Apr 4, 2016 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what THAR PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.